S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)

AcelRx Pharmaceuticals (ACRX) Insider Trading & Ownership

$0.86
+0.06 (+7.50%)
(As of 01/9/2024)

AcelRx Pharmaceuticals (NASDAQ:ACRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.00%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$15,300.00
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$11,131.38
Get ACRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling AcelRx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ACRX Insider Buying and Selling by Quarter


AcelRx Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/13/2023Vincent J AngottiCEOBuy10,000$0.73$7,300.00  
9/11/2023Vincent J AngottiCEOBuy10,000$0.80$8,000.00  
8/24/2023Pamela P PalmerInsiderSell9,514$1.17$11,131.38  
(Data available from 1/1/2013 forward)












ACRX Insider Trading Activity - Frequently Asked Questions

Who is on AcelRx Pharmaceuticals's Insider Roster?

The list of insiders at AcelRx Pharmaceuticals includes Pamela P Palmer, and Vincent J Angotti. Learn more on insiders at ACRX.

What percentage of AcelRx Pharmaceuticals stock is owned by insiders?

3.00% of AcelRx Pharmaceuticals stock is owned by insiders. Learn more on ACRX's insider holdings.

Which AcelRx Pharmaceuticals insiders have been buying company stock?

The following insider purchased ACRX shares in the last 24 months: Vincent J Angotti ($25,508.00).

How much insider buying is happening at AcelRx Pharmaceuticals?

Insiders have purchased a total of 66,400 ACRX shares in the last 24 months for a total of $25,508.00 bought.

Which AcelRx Pharmaceuticals insiders have been selling company stock?

The following insider sold ACRX shares in the last 24 months: Pamela P Palmer ($11,131.38).

How much insider selling is happening at AcelRx Pharmaceuticals?

Insiders have sold a total of 9,514 AcelRx Pharmaceuticals shares in the last 24 months for a total of $11,131.38 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:ACRX) was last updated on 2/26/2024 by MarketBeat.com Staff